Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07666048 · ClinicalTrials.gov registry record
Adapting Enhanced Supports to Improve Patient Adherence to Secondary Antibiotic Prophylaxis for Rheumatic Heart Disease
A clinical trial, sponsored by Children's Hospital Medical Center, Cincinnati.
- Not yet
- Registry status
- 308
- Enrollment target
NCT07666048: Clinical Trial study, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT07666048 is a clinical trial that has not yet begun recruiting, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 308 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07666048 has not yet begun recruiting, sponsored by Children's Hospital Medical Center, Cincinnati.
- NOT YET RECRUITING
- Registry status
- 308 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test the effectiveness and implementation of enhanced Secondary Antibiotic Prophylaxis (SAP) supports using a hybrid type 1 effectiveness-implementation design. The purpose is to determine whether enhanced SAP supports will increase average SAP adherence in Brazil and Timor-Leste. The study will enroll people living with Rheumatic Heart Disease (RHD) and Community Health Workers (CHWs) participating in the intervention. The main questions it aims to answer are: * Whether CHW-led supports delivered within the community improve mean SAP adherence at 12 months post-intervention. * Whether the intervention demonstrates acceptability, feasibility, uptake and engagement. Researchers will compare baseline and post-intervention SAP adherence data for the 12 months prior to and following intervention rollout to see if CHW-delivered supports increase adherence.
Primary Outcome
Proportion of participants reporting the intervention as acceptable (e.g., via standardized acceptability surveys) Proportion of intended intervention components successfully implemented (fidelity/adoption)
Interventions
- BEHAVIORAL CHW Delivered SAP Adherence Supports
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 308 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2030-12-31 |
What is known before NCT07666048 opens enrollment
NCT07666048 is an observational study that tracks outcomes without assigning an intervention. The registered 308 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which CHW Delivered SAP Adherence Supports is the first listed.
NCT07666048 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07666048 about?
NCT07666048 is a clinical study titled "Adapting Enhanced Supports to Improve Patient Adherence to Secondary Antibiotic Prophylaxis for Rheumatic Heart Disease". The goal of this clinical trial is to test the effectiveness and implementation of enhanced Secondary Antibiotic Prophylaxis (SAP) supports using a hybrid type 1 effectiveness-implementation design. The purpose is to determine whether enhanced SAP supports will increase average SAP adherence in Braz...
What is the current status of trial NCT07666048?
This trial is currently not yet recruiting. The enrollment target is 308 participants. The study started on 2026-06-01. Estimated completion is 2030-12-31.
What interventions are being tested in trial NCT07666048?
The interventions under investigation include: CHW Delivered SAP Adherence Supports (BEHAVIORAL).
Who is sponsoring clinical trial NCT07666048?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04162938 · 308 participants · NA
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
- NCT04955795 · 308 participants · NA
Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA
- NCT06090539 · 308 participants · Phase 1
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
- NCT06233942 · 308 participants · Phase 1
Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI